SlideShare ist ein Scribd-Unternehmen logo
1 von 1
Downloaden Sie, um offline zu lesen
Abstract
To find anti-cancer drugs, different cellular modifications can be looked at: cell death effect on proliferating cells either in 2D culture or on
spheroids (3D culture), anti-mitotic, anti-migration/invasion, anti-angiogenesis effects… Different assays can be performed to follow these
different effects. High content screening is a multi-parametric technology allowing searching for poly-effects drugs.
In this poster, several well known compounds were tested in 3 different assays: cytotoxicity in 2D culture, cytotoxicity in spheroids (3D
culture) and scratch assay (also named wound healing). These 3 models were automated in 96-well plates.
Methods
Results
Conclusions & Perspectives
 Automation on cytotoxicity assay on 3D culture in 96-well microplate and scratch assay (would healing) was successful.
 EC50 results on cytotoxicity assay in 3D culture show a shift towards higher concentrations compared to 2D culture. This is due to the
time required for the compound to reach the center of the spheroid. Depending on this time, the shift may be higher or lower. These 3D
results are more relevant compared to the in vivo situation. Nevertheless, to be the most relevant as possible to the in vivo tumor, the
spheroid needs to reach a consistent size. However, a necrotic core appears from the 3rd day in this condition (seeding: 2000 cells/well).
 Perspective: the relevance of this 3D model would be increased by the addition of angiogenesis step with co-culture of HUVEC.
 Scratch assay is another assay which proliferation/migration is followed and depending of the profile of the results, cell cycle arrest
inducers (as colchicine) can be distinguished from cell death inducers. The two actions of Vinblastine (cell cylce arrest between 0.01 and
0.1 µM and cell death inducer at higher concentration) can be better observed in this assay than in the cytotoxicity assay.
Cell culture: Hela (HT29, HepG2 or Caco-2: data not shown) were routinely maintained in DMEM (v/v) supplemented with 10% FBS. Depending of the cell line,
cells were seeded between 2 500 and 10 000 cells/well in 96-well plates for 2D culture (Corning® cell-bind or Greiner® plates) or at 2000 cells/well in 96-well
Corning® Spheroid microplates for 3D culture. Then, cells were incubated at 37 °C in 5 % CO2 for plating. The medium was changed every 3 days if needed.
Cytotoxicity assay on 2D and 3D culture: After 48h of plating, cytotoxicity assay was performed by replaced medium in each well by fresh medium with or
without different anti-cancer drugs at different concentrations added by Hoechst (1/1000) and propidium iodide (1/1000).
Wound healing assay: When cells are at confluence, a scratch was performed in each well on a robotic platform with a 96-well head (Caliper ALH3000, Perkin
Elmer). Medium was changed and replaced as previously. Then cells were incubated at 37 °C in 5 % CO2 for several days.
Live cells imaging: Each day, pictures were taken on operetta (Perkin Elmer). Analysis and visualization were performed on Columbus (Perkin Elmer).
Cytotoxicity assay on 2D & 3D culture
Colchicine
Automated wound healing on 96-well plates
To get this poster,
please flash the QR-
code
You can use the
I-NIGMA application
from your store
Cmax - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Cmin CTRL
Cisplatine
Colchicine
Cyclophosphamide
Etoposide
Paclitaxel
Staurosporine
Vinblastine
Compound X
T0 T48h
Cmax - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Cmin CTRL
Blue: Hoecsht, Yellow: Propidium iodide
%Surfacescratched/T0
[Colchicine] (µM)
CTRL T0 CTRL T48h
%Surfacescratched/T0
[vinblastine] (µM)
Blue: Hoecsht, Yellow: Propidium iodide
Heatmap of T48h plate
CTRL cells Vinblastine 1 µM
EC50=106 nM
EC50=149 nM
2D
3D
100 µM 30 µM 10 µM 3 µM 1 µM 300 nM 100 nM 30 nM 10 nM 3 nM CTRL
2D
3D
Vinblastine
2D
2D
3D
CTRL cells Etoposide 1 µM
100 µM 30 µM 10 µM 3 µM 1 µM 300 nM 100 nM 30 nM 10 nM 3 nM CTRL
Etoposide
30nM> EC50 >100nM
EC50> 100 nM
High Content Screening of automated wound healing and
cytotoxicity assays in 2D and 3D culture
MAUBON N.1*, ROUDAUT M.1, NDOYE A.2 & BURSZTYKA J.1
1 HCS Pharma, 6 rue Pierre Joseph Colin, 35000 Rennes
2 Perkin Elmer , 16 av Québec, Bât Lys, 91140 Villebon sur Yvette
1*nathalie.maubon@hcs-pharma.com
Vinblastine
Cmax - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Cmin CTRL
2 days
3 days
4 days
5 days
2 days
3 days
4 days
5 days
Cmax - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Cmin CTRL
etoposide
Time and dose effect on
3D culture

Weitere ähnliche Inhalte

Was ist angesagt?

Fluorescence activated cell sorted assay for Gaucher's disease
Fluorescence activated cell sorted assay for Gaucher's diseaseFluorescence activated cell sorted assay for Gaucher's disease
Fluorescence activated cell sorted assay for Gaucher's diseaseMayank Sagar
 
regulatory t cells and gvhd
regulatory t cells and gvhdregulatory t cells and gvhd
regulatory t cells and gvhdspa718
 
HepG2 cell model for genotoxicity and steatosis assessment
HepG2 cell model for genotoxicity and steatosis assessmentHepG2 cell model for genotoxicity and steatosis assessment
HepG2 cell model for genotoxicity and steatosis assessmentHCS Pharma
 
DR5-B – DR5-selective mutant variant of cytokine TRAIL overcomes resistance o...
DR5-B – DR5-selective mutant variant of cytokine TRAIL overcomes resistance o...DR5-B – DR5-selective mutant variant of cytokine TRAIL overcomes resistance o...
DR5-B – DR5-selective mutant variant of cytokine TRAIL overcomes resistance o...1411440424max
 
Development of cell culture samples for drug screening with bone marrow stem ...
Development of cell culture samples for drug screening with bone marrow stem ...Development of cell culture samples for drug screening with bone marrow stem ...
Development of cell culture samples for drug screening with bone marrow stem ...Apollo Hospitals
 
Ph D Swati Dhar
Ph D Swati DharPh D Swati Dhar
Ph D Swati DharSwati Dhar
 
The Effect of Atorvastatin (Lipitor) on the Duration of Survival of Allogenei...
The Effect of Atorvastatin (Lipitor) on the Duration of Survival of Allogenei...The Effect of Atorvastatin (Lipitor) on the Duration of Survival of Allogenei...
The Effect of Atorvastatin (Lipitor) on the Duration of Survival of Allogenei...Nabil Zeidan
 
Jeremy Cohen - Raging Hormones and the Critically Ill
Jeremy Cohen - Raging Hormones and the Critically IllJeremy Cohen - Raging Hormones and the Critically Ill
Jeremy Cohen - Raging Hormones and the Critically IllSMACC Conference
 
en%2E2014-1318
en%2E2014-1318en%2E2014-1318
en%2E2014-1318Amyn Murji
 
William Kay YIG 2
William Kay YIG 2William Kay YIG 2
William Kay YIG 2William Kay
 
Lnc rna neat1 is involved in temozolomide resistance by regulating mgmt in gl...
Lnc rna neat1 is involved in temozolomide resistance by regulating mgmt in gl...Lnc rna neat1 is involved in temozolomide resistance by regulating mgmt in gl...
Lnc rna neat1 is involved in temozolomide resistance by regulating mgmt in gl...Clinical Surgery Research Communications
 
Regulatory T Cells and GVHD
Regulatory T Cells and GVHDRegulatory T Cells and GVHD
Regulatory T Cells and GVHDspa718
 
mulenga final presentation 8.21
mulenga  final presentation 8.21mulenga  final presentation 8.21
mulenga final presentation 8.21mulenga chileshe
 

Was ist angesagt? (18)

Shamah MCB 93
Shamah MCB 93Shamah MCB 93
Shamah MCB 93
 
Fluorescence activated cell sorted assay for Gaucher's disease
Fluorescence activated cell sorted assay for Gaucher's diseaseFluorescence activated cell sorted assay for Gaucher's disease
Fluorescence activated cell sorted assay for Gaucher's disease
 
regulatory t cells and gvhd
regulatory t cells and gvhdregulatory t cells and gvhd
regulatory t cells and gvhd
 
Vumc poster
Vumc posterVumc poster
Vumc poster
 
HepG2 cell model for genotoxicity and steatosis assessment
HepG2 cell model for genotoxicity and steatosis assessmentHepG2 cell model for genotoxicity and steatosis assessment
HepG2 cell model for genotoxicity and steatosis assessment
 
DR5-B – DR5-selective mutant variant of cytokine TRAIL overcomes resistance o...
DR5-B – DR5-selective mutant variant of cytokine TRAIL overcomes resistance o...DR5-B – DR5-selective mutant variant of cytokine TRAIL overcomes resistance o...
DR5-B – DR5-selective mutant variant of cytokine TRAIL overcomes resistance o...
 
Esnrt poster cd20
Esnrt poster cd20Esnrt poster cd20
Esnrt poster cd20
 
Development of cell culture samples for drug screening with bone marrow stem ...
Development of cell culture samples for drug screening with bone marrow stem ...Development of cell culture samples for drug screening with bone marrow stem ...
Development of cell culture samples for drug screening with bone marrow stem ...
 
poster isev
poster isevposter isev
poster isev
 
Ph D Swati Dhar
Ph D Swati DharPh D Swati Dhar
Ph D Swati Dhar
 
The Effect of Atorvastatin (Lipitor) on the Duration of Survival of Allogenei...
The Effect of Atorvastatin (Lipitor) on the Duration of Survival of Allogenei...The Effect of Atorvastatin (Lipitor) on the Duration of Survival of Allogenei...
The Effect of Atorvastatin (Lipitor) on the Duration of Survival of Allogenei...
 
Jeremy Cohen - Raging Hormones and the Critically Ill
Jeremy Cohen - Raging Hormones and the Critically IllJeremy Cohen - Raging Hormones and the Critically Ill
Jeremy Cohen - Raging Hormones and the Critically Ill
 
en%2E2014-1318
en%2E2014-1318en%2E2014-1318
en%2E2014-1318
 
William Kay YIG 2
William Kay YIG 2William Kay YIG 2
William Kay YIG 2
 
Caspase Dependent Apoptosis is Only Inhibited on Γ Irradiation of Cells Condi...
Caspase Dependent Apoptosis is Only Inhibited on Γ Irradiation of Cells Condi...Caspase Dependent Apoptosis is Only Inhibited on Γ Irradiation of Cells Condi...
Caspase Dependent Apoptosis is Only Inhibited on Γ Irradiation of Cells Condi...
 
Lnc rna neat1 is involved in temozolomide resistance by regulating mgmt in gl...
Lnc rna neat1 is involved in temozolomide resistance by regulating mgmt in gl...Lnc rna neat1 is involved in temozolomide resistance by regulating mgmt in gl...
Lnc rna neat1 is involved in temozolomide resistance by regulating mgmt in gl...
 
Regulatory T Cells and GVHD
Regulatory T Cells and GVHDRegulatory T Cells and GVHD
Regulatory T Cells and GVHD
 
mulenga final presentation 8.21
mulenga  final presentation 8.21mulenga  final presentation 8.21
mulenga final presentation 8.21
 

Ähnlich wie High Content Screening of automated wound healing and cytotoxicity assays in 2D and 3D culture

Stemline® XF MSC Medium has High Yield and Functionality in the 3 L Mobius® S...
Stemline® XF MSC Medium has High Yield and Functionality in the 3 L Mobius® S...Stemline® XF MSC Medium has High Yield and Functionality in the 3 L Mobius® S...
Stemline® XF MSC Medium has High Yield and Functionality in the 3 L Mobius® S...MilliporeSigma
 
From syngenic to_humanised_models_mirjolet_oncodesign
From syngenic to_humanised_models_mirjolet_oncodesignFrom syngenic to_humanised_models_mirjolet_oncodesign
From syngenic to_humanised_models_mirjolet_oncodesignFlorence Fombertasse
 
Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...
Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...
Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...HCS Pharma
 
IN VITRO EVALUATION OF CYTOTOXIC ACTIVITY OF HYDRAZIDEHYDRAZONES BASED ON 4-C...
IN VITRO EVALUATION OF CYTOTOXIC ACTIVITY OF HYDRAZIDEHYDRAZONES BASED ON 4-C...IN VITRO EVALUATION OF CYTOTOXIC ACTIVITY OF HYDRAZIDEHYDRAZONES BASED ON 4-C...
IN VITRO EVALUATION OF CYTOTOXIC ACTIVITY OF HYDRAZIDEHYDRAZONES BASED ON 4-C...Dimo Angelov
 
Maytansinoid immunoconjugate IMGN901 is cytotoxic
Maytansinoid immunoconjugate IMGN901 is cytotoxicMaytansinoid immunoconjugate IMGN901 is cytotoxic
Maytansinoid immunoconjugate IMGN901 is cytotoxicEllen Gunn
 
Anticancer drug screening
Anticancer drug screeningAnticancer drug screening
Anticancer drug screeningshishirkawde
 
Flow Cytometry Chemotaxis
Flow Cytometry ChemotaxisFlow Cytometry Chemotaxis
Flow Cytometry ChemotaxisAdrian Freeman
 
immunohistochemically and in situ hybridizati.pptx
immunohistochemically and in situ hybridizati.pptximmunohistochemically and in situ hybridizati.pptx
immunohistochemically and in situ hybridizati.pptxMarwa972783
 
immunohistochemically and in situ hybridizati.pptx
immunohistochemically and in situ hybridizati.pptximmunohistochemically and in situ hybridizati.pptx
immunohistochemically and in situ hybridizati.pptxMarwa972783
 
Medical review of medolife’s escozine tm technology in pre clinical & cli...
Medical review of medolife’s escozine tm technology in pre clinical & cli...Medical review of medolife’s escozine tm technology in pre clinical & cli...
Medical review of medolife’s escozine tm technology in pre clinical & cli...PetLife Pharmaceuticals Inc
 
Molecular med tricon 2017 poster printed
Molecular med tricon 2017 poster printedMolecular med tricon 2017 poster printed
Molecular med tricon 2017 poster printedRandyLyEIT
 
Neuromics base presentation 2020 with Virus Transport Media
Neuromics base presentation 2020 with Virus Transport MediaNeuromics base presentation 2020 with Virus Transport Media
Neuromics base presentation 2020 with Virus Transport MediaPete Shuster
 
EHA poster Genomic Analysis by MyAML with Chemotherapy
EHA poster Genomic Analysis by MyAML with ChemotherapyEHA poster Genomic Analysis by MyAML with Chemotherapy
EHA poster Genomic Analysis by MyAML with ChemotherapySuzanne M. Graham
 
Freiburg Nk2009 Jan Spanholtz
Freiburg Nk2009 Jan SpanholtzFreiburg Nk2009 Jan Spanholtz
Freiburg Nk2009 Jan SpanholtzJanSpanholtz
 
nihms95470
nihms95470nihms95470
nihms95470Xing Su
 
Microsoft power point presentation of master research at uwe, bristol
Microsoft power point presentation of master research at uwe, bristolMicrosoft power point presentation of master research at uwe, bristol
Microsoft power point presentation of master research at uwe, bristolMONTADAR AL-AZZAWI
 
JTM-Functional characterization of human Cd33+ And Cd11b+ myeloid-derived sup...
JTM-Functional characterization of human Cd33+ And Cd11b+ myeloid-derived sup...JTM-Functional characterization of human Cd33+ And Cd11b+ myeloid-derived sup...
JTM-Functional characterization of human Cd33+ And Cd11b+ myeloid-derived sup...Karolina Megiel
 
Gene expression profiling in apoptotic mcf 7 cells infected with newcastle di...
Gene expression profiling in apoptotic mcf 7 cells infected with newcastle di...Gene expression profiling in apoptotic mcf 7 cells infected with newcastle di...
Gene expression profiling in apoptotic mcf 7 cells infected with newcastle di...Mohamed Khalid Ali Xundhur
 

Ähnlich wie High Content Screening of automated wound healing and cytotoxicity assays in 2D and 3D culture (20)

Stemline® XF MSC Medium has High Yield and Functionality in the 3 L Mobius® S...
Stemline® XF MSC Medium has High Yield and Functionality in the 3 L Mobius® S...Stemline® XF MSC Medium has High Yield and Functionality in the 3 L Mobius® S...
Stemline® XF MSC Medium has High Yield and Functionality in the 3 L Mobius® S...
 
From syngenic to_humanised_models_mirjolet_oncodesign
From syngenic to_humanised_models_mirjolet_oncodesignFrom syngenic to_humanised_models_mirjolet_oncodesign
From syngenic to_humanised_models_mirjolet_oncodesign
 
Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...
Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...
Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...
 
anti tumor 1.doc
anti tumor 1.docanti tumor 1.doc
anti tumor 1.doc
 
IN VITRO EVALUATION OF CYTOTOXIC ACTIVITY OF HYDRAZIDEHYDRAZONES BASED ON 4-C...
IN VITRO EVALUATION OF CYTOTOXIC ACTIVITY OF HYDRAZIDEHYDRAZONES BASED ON 4-C...IN VITRO EVALUATION OF CYTOTOXIC ACTIVITY OF HYDRAZIDEHYDRAZONES BASED ON 4-C...
IN VITRO EVALUATION OF CYTOTOXIC ACTIVITY OF HYDRAZIDEHYDRAZONES BASED ON 4-C...
 
Maytansinoid immunoconjugate IMGN901 is cytotoxic
Maytansinoid immunoconjugate IMGN901 is cytotoxicMaytansinoid immunoconjugate IMGN901 is cytotoxic
Maytansinoid immunoconjugate IMGN901 is cytotoxic
 
Anticancer drug screening
Anticancer drug screeningAnticancer drug screening
Anticancer drug screening
 
Flow Cytometry Chemotaxis
Flow Cytometry ChemotaxisFlow Cytometry Chemotaxis
Flow Cytometry Chemotaxis
 
immunohistochemically and in situ hybridizati.pptx
immunohistochemically and in situ hybridizati.pptximmunohistochemically and in situ hybridizati.pptx
immunohistochemically and in situ hybridizati.pptx
 
immunohistochemically and in situ hybridizati.pptx
immunohistochemically and in situ hybridizati.pptximmunohistochemically and in situ hybridizati.pptx
immunohistochemically and in situ hybridizati.pptx
 
Medical review of medolife’s escozine tm technology in pre clinical & cli...
Medical review of medolife’s escozine tm technology in pre clinical & cli...Medical review of medolife’s escozine tm technology in pre clinical & cli...
Medical review of medolife’s escozine tm technology in pre clinical & cli...
 
Molecular med tricon 2017 poster printed
Molecular med tricon 2017 poster printedMolecular med tricon 2017 poster printed
Molecular med tricon 2017 poster printed
 
Neuromics base presentation 2020 with Virus Transport Media
Neuromics base presentation 2020 with Virus Transport MediaNeuromics base presentation 2020 with Virus Transport Media
Neuromics base presentation 2020 with Virus Transport Media
 
EHA poster Genomic Analysis by MyAML with Chemotherapy
EHA poster Genomic Analysis by MyAML with ChemotherapyEHA poster Genomic Analysis by MyAML with Chemotherapy
EHA poster Genomic Analysis by MyAML with Chemotherapy
 
Freiburg Nk2009 Jan Spanholtz
Freiburg Nk2009 Jan SpanholtzFreiburg Nk2009 Jan Spanholtz
Freiburg Nk2009 Jan Spanholtz
 
publi Toulouse
publi Toulousepubli Toulouse
publi Toulouse
 
nihms95470
nihms95470nihms95470
nihms95470
 
Microsoft power point presentation of master research at uwe, bristol
Microsoft power point presentation of master research at uwe, bristolMicrosoft power point presentation of master research at uwe, bristol
Microsoft power point presentation of master research at uwe, bristol
 
JTM-Functional characterization of human Cd33+ And Cd11b+ myeloid-derived sup...
JTM-Functional characterization of human Cd33+ And Cd11b+ myeloid-derived sup...JTM-Functional characterization of human Cd33+ And Cd11b+ myeloid-derived sup...
JTM-Functional characterization of human Cd33+ And Cd11b+ myeloid-derived sup...
 
Gene expression profiling in apoptotic mcf 7 cells infected with newcastle di...
Gene expression profiling in apoptotic mcf 7 cells infected with newcastle di...Gene expression profiling in apoptotic mcf 7 cells infected with newcastle di...
Gene expression profiling in apoptotic mcf 7 cells infected with newcastle di...
 

Mehr von HCS Pharma

Poster HCSPHARMA (OncoLilleDays2022) - Mechanobiological characterization of ...
Poster HCSPHARMA (OncoLilleDays2022) - Mechanobiological characterization of ...Poster HCSPHARMA (OncoLilleDays2022) - Mechanobiological characterization of ...
Poster HCSPHARMA (OncoLilleDays2022) - Mechanobiological characterization of ...HCS Pharma
 
Poster : Development of personalized therapeutic targeting in lung cancer wit...
Poster : Development of personalized therapeutic targeting in lung cancer wit...Poster : Development of personalized therapeutic targeting in lung cancer wit...
Poster : Development of personalized therapeutic targeting in lung cancer wit...HCS Pharma
 
Poster - Including the matricial tumoral microenvironment in 3D in vitro mode...
Poster - Including the matricial tumoral microenvironment in 3D in vitro mode...Poster - Including the matricial tumoral microenvironment in 3D in vitro mode...
Poster - Including the matricial tumoral microenvironment in 3D in vitro mode...HCS Pharma
 
HCS PHARMA - (ECM 2022) Development of innovative hiPSC-based model including...
HCS PHARMA - (ECM 2022) Development of innovative hiPSC-based model including...HCS PHARMA - (ECM 2022) Development of innovative hiPSC-based model including...
HCS PHARMA - (ECM 2022) Development of innovative hiPSC-based model including...HCS Pharma
 
HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...
HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...
HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...HCS Pharma
 
Poster - A single procedure to generate functional hiPSCs-derived liver organ...
Poster - A single procedure to generate functional hiPSCs-derived liver organ...Poster - A single procedure to generate functional hiPSCs-derived liver organ...
Poster - A single procedure to generate functional hiPSCs-derived liver organ...HCS Pharma
 
Poster - BIOMIMESYS® 3D hydroscaffold a matricial microenvironment for physio...
Poster - BIOMIMESYS® 3D hydroscaffold a matricial microenvironment for physio...Poster - BIOMIMESYS® 3D hydroscaffold a matricial microenvironment for physio...
Poster - BIOMIMESYS® 3D hydroscaffold a matricial microenvironment for physio...HCS Pharma
 
BIOMIMESYS® Liver
BIOMIMESYS® LiverBIOMIMESYS® Liver
BIOMIMESYS® LiverHCS Pharma
 
BIOMIMESYS® Adipose tissue
BIOMIMESYS® Adipose tissueBIOMIMESYS® Adipose tissue
BIOMIMESYS® Adipose tissueHCS Pharma
 
BIOMIMESYS® Oncology
BIOMIMESYS® OncologyBIOMIMESYS® Oncology
BIOMIMESYS® OncologyHCS Pharma
 
Importance of matricial and cellular microenvironments in in vitro models for...
Importance of matricial and cellular microenvironments in in vitro models for...Importance of matricial and cellular microenvironments in in vitro models for...
Importance of matricial and cellular microenvironments in in vitro models for...HCS Pharma
 
Simplifying 3d cell culture generation for high content screening with BIOMIM...
Simplifying 3d cell culture generation for high content screening with BIOMIM...Simplifying 3d cell culture generation for high content screening with BIOMIM...
Simplifying 3d cell culture generation for high content screening with BIOMIM...HCS Pharma
 
BIOMIMESYS®Liver, a 3D cell culture model for maintaining and promoting hepat...
BIOMIMESYS®Liver, a 3D cell culture model for maintaining and promoting hepat...BIOMIMESYS®Liver, a 3D cell culture model for maintaining and promoting hepat...
BIOMIMESYS®Liver, a 3D cell culture model for maintaining and promoting hepat...HCS Pharma
 
Abstract : a single procedure to generate functional hi ps cs-derived liver o...
Abstract : a single procedure to generate functional hi ps cs-derived liver o...Abstract : a single procedure to generate functional hi ps cs-derived liver o...
Abstract : a single procedure to generate functional hi ps cs-derived liver o...HCS Pharma
 
Poster – Development and automation of 3D innovative hiPSC-based liver organo...
Poster – Development and automation of 3D innovative hiPSC-based liver organo...Poster – Development and automation of 3D innovative hiPSC-based liver organo...
Poster – Development and automation of 3D innovative hiPSC-based liver organo...HCS Pharma
 
Poster – Development and automation of 3D innovative hiPSC-based liver organo...
Poster – Development	and	automation of 3D innovative	hiPSC-based liver organo...Poster – Development	and	automation of 3D innovative	hiPSC-based liver organo...
Poster – Development and automation of 3D innovative hiPSC-based liver organo...HCS Pharma
 
Development of a new liver-on-chip including BIOMIMESYS® technology for mimic...
Development of a new liver-on-chip including BIOMIMESYS® technology for mimic...Development of a new liver-on-chip including BIOMIMESYS® technology for mimic...
Development of a new liver-on-chip including BIOMIMESYS® technology for mimic...HCS Pharma
 
HCS Pharma complète sa gamme de culture cellulaire en 3D BIOMIMESYS® avec BIO...
HCS Pharma complète sa gamme de culture cellulaire en 3D BIOMIMESYS® avec BIO...HCS Pharma complète sa gamme de culture cellulaire en 3D BIOMIMESYS® avec BIO...
HCS Pharma complète sa gamme de culture cellulaire en 3D BIOMIMESYS® avec BIO...HCS Pharma
 
HCS Pharma extends its 3D cell culture range BIOMIMESYS® with BIOMIMESYS® Brain
HCS Pharma extends its 3D cell culture range BIOMIMESYS® with BIOMIMESYS® BrainHCS Pharma extends its 3D cell culture range BIOMIMESYS® with BIOMIMESYS® Brain
HCS Pharma extends its 3D cell culture range BIOMIMESYS® with BIOMIMESYS® BrainHCS Pharma
 
A groundbreaking 3D cell culture technology for HCS: BIOMIMESYS hydroscaffold
A groundbreaking 3D cell culture technology for HCS: BIOMIMESYS hydroscaffoldA groundbreaking 3D cell culture technology for HCS: BIOMIMESYS hydroscaffold
A groundbreaking 3D cell culture technology for HCS: BIOMIMESYS hydroscaffoldHCS Pharma
 

Mehr von HCS Pharma (20)

Poster HCSPHARMA (OncoLilleDays2022) - Mechanobiological characterization of ...
Poster HCSPHARMA (OncoLilleDays2022) - Mechanobiological characterization of ...Poster HCSPHARMA (OncoLilleDays2022) - Mechanobiological characterization of ...
Poster HCSPHARMA (OncoLilleDays2022) - Mechanobiological characterization of ...
 
Poster : Development of personalized therapeutic targeting in lung cancer wit...
Poster : Development of personalized therapeutic targeting in lung cancer wit...Poster : Development of personalized therapeutic targeting in lung cancer wit...
Poster : Development of personalized therapeutic targeting in lung cancer wit...
 
Poster - Including the matricial tumoral microenvironment in 3D in vitro mode...
Poster - Including the matricial tumoral microenvironment in 3D in vitro mode...Poster - Including the matricial tumoral microenvironment in 3D in vitro mode...
Poster - Including the matricial tumoral microenvironment in 3D in vitro mode...
 
HCS PHARMA - (ECM 2022) Development of innovative hiPSC-based model including...
HCS PHARMA - (ECM 2022) Development of innovative hiPSC-based model including...HCS PHARMA - (ECM 2022) Development of innovative hiPSC-based model including...
HCS PHARMA - (ECM 2022) Development of innovative hiPSC-based model including...
 
HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...
HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...
HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...
 
Poster - A single procedure to generate functional hiPSCs-derived liver organ...
Poster - A single procedure to generate functional hiPSCs-derived liver organ...Poster - A single procedure to generate functional hiPSCs-derived liver organ...
Poster - A single procedure to generate functional hiPSCs-derived liver organ...
 
Poster - BIOMIMESYS® 3D hydroscaffold a matricial microenvironment for physio...
Poster - BIOMIMESYS® 3D hydroscaffold a matricial microenvironment for physio...Poster - BIOMIMESYS® 3D hydroscaffold a matricial microenvironment for physio...
Poster - BIOMIMESYS® 3D hydroscaffold a matricial microenvironment for physio...
 
BIOMIMESYS® Liver
BIOMIMESYS® LiverBIOMIMESYS® Liver
BIOMIMESYS® Liver
 
BIOMIMESYS® Adipose tissue
BIOMIMESYS® Adipose tissueBIOMIMESYS® Adipose tissue
BIOMIMESYS® Adipose tissue
 
BIOMIMESYS® Oncology
BIOMIMESYS® OncologyBIOMIMESYS® Oncology
BIOMIMESYS® Oncology
 
Importance of matricial and cellular microenvironments in in vitro models for...
Importance of matricial and cellular microenvironments in in vitro models for...Importance of matricial and cellular microenvironments in in vitro models for...
Importance of matricial and cellular microenvironments in in vitro models for...
 
Simplifying 3d cell culture generation for high content screening with BIOMIM...
Simplifying 3d cell culture generation for high content screening with BIOMIM...Simplifying 3d cell culture generation for high content screening with BIOMIM...
Simplifying 3d cell culture generation for high content screening with BIOMIM...
 
BIOMIMESYS®Liver, a 3D cell culture model for maintaining and promoting hepat...
BIOMIMESYS®Liver, a 3D cell culture model for maintaining and promoting hepat...BIOMIMESYS®Liver, a 3D cell culture model for maintaining and promoting hepat...
BIOMIMESYS®Liver, a 3D cell culture model for maintaining and promoting hepat...
 
Abstract : a single procedure to generate functional hi ps cs-derived liver o...
Abstract : a single procedure to generate functional hi ps cs-derived liver o...Abstract : a single procedure to generate functional hi ps cs-derived liver o...
Abstract : a single procedure to generate functional hi ps cs-derived liver o...
 
Poster – Development and automation of 3D innovative hiPSC-based liver organo...
Poster – Development and automation of 3D innovative hiPSC-based liver organo...Poster – Development and automation of 3D innovative hiPSC-based liver organo...
Poster – Development and automation of 3D innovative hiPSC-based liver organo...
 
Poster – Development and automation of 3D innovative hiPSC-based liver organo...
Poster – Development	and	automation of 3D innovative	hiPSC-based liver organo...Poster – Development	and	automation of 3D innovative	hiPSC-based liver organo...
Poster – Development and automation of 3D innovative hiPSC-based liver organo...
 
Development of a new liver-on-chip including BIOMIMESYS® technology for mimic...
Development of a new liver-on-chip including BIOMIMESYS® technology for mimic...Development of a new liver-on-chip including BIOMIMESYS® technology for mimic...
Development of a new liver-on-chip including BIOMIMESYS® technology for mimic...
 
HCS Pharma complète sa gamme de culture cellulaire en 3D BIOMIMESYS® avec BIO...
HCS Pharma complète sa gamme de culture cellulaire en 3D BIOMIMESYS® avec BIO...HCS Pharma complète sa gamme de culture cellulaire en 3D BIOMIMESYS® avec BIO...
HCS Pharma complète sa gamme de culture cellulaire en 3D BIOMIMESYS® avec BIO...
 
HCS Pharma extends its 3D cell culture range BIOMIMESYS® with BIOMIMESYS® Brain
HCS Pharma extends its 3D cell culture range BIOMIMESYS® with BIOMIMESYS® BrainHCS Pharma extends its 3D cell culture range BIOMIMESYS® with BIOMIMESYS® Brain
HCS Pharma extends its 3D cell culture range BIOMIMESYS® with BIOMIMESYS® Brain
 
A groundbreaking 3D cell culture technology for HCS: BIOMIMESYS hydroscaffold
A groundbreaking 3D cell culture technology for HCS: BIOMIMESYS hydroscaffoldA groundbreaking 3D cell culture technology for HCS: BIOMIMESYS hydroscaffold
A groundbreaking 3D cell culture technology for HCS: BIOMIMESYS hydroscaffold
 

Kürzlich hochgeladen

Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxvirengeeta
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxbkling
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptMumux Mirani
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 

Kürzlich hochgeladen (20)

Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptx
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 

High Content Screening of automated wound healing and cytotoxicity assays in 2D and 3D culture

  • 1. Abstract To find anti-cancer drugs, different cellular modifications can be looked at: cell death effect on proliferating cells either in 2D culture or on spheroids (3D culture), anti-mitotic, anti-migration/invasion, anti-angiogenesis effects… Different assays can be performed to follow these different effects. High content screening is a multi-parametric technology allowing searching for poly-effects drugs. In this poster, several well known compounds were tested in 3 different assays: cytotoxicity in 2D culture, cytotoxicity in spheroids (3D culture) and scratch assay (also named wound healing). These 3 models were automated in 96-well plates. Methods Results Conclusions & Perspectives  Automation on cytotoxicity assay on 3D culture in 96-well microplate and scratch assay (would healing) was successful.  EC50 results on cytotoxicity assay in 3D culture show a shift towards higher concentrations compared to 2D culture. This is due to the time required for the compound to reach the center of the spheroid. Depending on this time, the shift may be higher or lower. These 3D results are more relevant compared to the in vivo situation. Nevertheless, to be the most relevant as possible to the in vivo tumor, the spheroid needs to reach a consistent size. However, a necrotic core appears from the 3rd day in this condition (seeding: 2000 cells/well).  Perspective: the relevance of this 3D model would be increased by the addition of angiogenesis step with co-culture of HUVEC.  Scratch assay is another assay which proliferation/migration is followed and depending of the profile of the results, cell cycle arrest inducers (as colchicine) can be distinguished from cell death inducers. The two actions of Vinblastine (cell cylce arrest between 0.01 and 0.1 µM and cell death inducer at higher concentration) can be better observed in this assay than in the cytotoxicity assay. Cell culture: Hela (HT29, HepG2 or Caco-2: data not shown) were routinely maintained in DMEM (v/v) supplemented with 10% FBS. Depending of the cell line, cells were seeded between 2 500 and 10 000 cells/well in 96-well plates for 2D culture (Corning® cell-bind or Greiner® plates) or at 2000 cells/well in 96-well Corning® Spheroid microplates for 3D culture. Then, cells were incubated at 37 °C in 5 % CO2 for plating. The medium was changed every 3 days if needed. Cytotoxicity assay on 2D and 3D culture: After 48h of plating, cytotoxicity assay was performed by replaced medium in each well by fresh medium with or without different anti-cancer drugs at different concentrations added by Hoechst (1/1000) and propidium iodide (1/1000). Wound healing assay: When cells are at confluence, a scratch was performed in each well on a robotic platform with a 96-well head (Caliper ALH3000, Perkin Elmer). Medium was changed and replaced as previously. Then cells were incubated at 37 °C in 5 % CO2 for several days. Live cells imaging: Each day, pictures were taken on operetta (Perkin Elmer). Analysis and visualization were performed on Columbus (Perkin Elmer). Cytotoxicity assay on 2D & 3D culture Colchicine Automated wound healing on 96-well plates To get this poster, please flash the QR- code You can use the I-NIGMA application from your store Cmax - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Cmin CTRL Cisplatine Colchicine Cyclophosphamide Etoposide Paclitaxel Staurosporine Vinblastine Compound X T0 T48h Cmax - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Cmin CTRL Blue: Hoecsht, Yellow: Propidium iodide %Surfacescratched/T0 [Colchicine] (µM) CTRL T0 CTRL T48h %Surfacescratched/T0 [vinblastine] (µM) Blue: Hoecsht, Yellow: Propidium iodide Heatmap of T48h plate CTRL cells Vinblastine 1 µM EC50=106 nM EC50=149 nM 2D 3D 100 µM 30 µM 10 µM 3 µM 1 µM 300 nM 100 nM 30 nM 10 nM 3 nM CTRL 2D 3D Vinblastine 2D 2D 3D CTRL cells Etoposide 1 µM 100 µM 30 µM 10 µM 3 µM 1 µM 300 nM 100 nM 30 nM 10 nM 3 nM CTRL Etoposide 30nM> EC50 >100nM EC50> 100 nM High Content Screening of automated wound healing and cytotoxicity assays in 2D and 3D culture MAUBON N.1*, ROUDAUT M.1, NDOYE A.2 & BURSZTYKA J.1 1 HCS Pharma, 6 rue Pierre Joseph Colin, 35000 Rennes 2 Perkin Elmer , 16 av Québec, Bât Lys, 91140 Villebon sur Yvette 1*nathalie.maubon@hcs-pharma.com Vinblastine Cmax - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Cmin CTRL 2 days 3 days 4 days 5 days 2 days 3 days 4 days 5 days Cmax - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Cmin CTRL etoposide Time and dose effect on 3D culture